Document is current

Any future updates will be listed below

Erratum to: Do We Need another Antiangiogenesis Agent for Colorectal Cancer: are Bevacizumab and Aflibercept the Same?

Crossref DOI link: https://doi.org/10.1007/s11888-014-0228-3

Published Online: 2014-05-28

Published Print: 2014-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark